The proteasome: a new `irrational' target for cancer treatment

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1394, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome as an Emerging Therapeutic Target in Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 471-485

Bentham Science Publishers

Access to resources Recommend Favorite

New target agents in the treatment of colorectal cancer patients

By Tonini Giuseppe   Schiavon Gaia   Vincenzi Bruno   Santini Daniele  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 861-871

Informa Healthcare

Access to resources Recommend Favorite

A new target for proteasome inhibitors: FoxM1

By Gartel Andrei L  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 235-242

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Marketed Proteasome Inhibitors for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 20, Iss. 20, 2013-07 ,pp. : 2537-2551

Bentham Science Publishers

Access to resources Recommend Favorite

The new paradigm in the treatment of colorectal cancer: are we hitting the right target?

By Baranda Joaquina   Williamson Stephen  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 311-324

Informa Healthcare

Access to resources Recommend Favorite